Post Reply
81-100 of 1197
Bought back 64 after profit taking today tmr hopefully above 70 since become profits liao 😆
This one bull vs bear.....
Those who bought recently at 63 and below will be tempted to take profit.
I view the weak price now is a good opportunity to add more especially the price is still below the placement shares sold recently.
The Trendlines Group reports net profit of US$1.9 mil in FY2025
Trendlines reported a net profit of US$1.9 million in FY2025, a significant turnaround from a loss of US$9.4 million the previous year. This was primarily due to a net gain of US$7.1 million in the fair value of portfolio companies, driven by favourable fundraising terms and progress in commercial or technological areas.
No power tio selling down
Stocky901 ( Date: 25-Feb-2026 10:14) Posted:
Yes.. 🖐 ️ testing 7 series soon. . don't miss ..
biper66 ( Date: 25-Feb-2026 08:01) Posted:
|
|
|
Yes.. 🖐 ️ testing 7 series soon. . don't miss ..
biper66 ( Date: 25-Feb-2026 08:01) Posted:
7c?
Stocky901 ( Date: 24-Feb-2026 18:34) Posted:
| Profits us$1.9m ..👍 .. should gap up at opening tomorrow.. let's see. |
|
|
|
7c?
Stocky901 ( Date: 24-Feb-2026 18:34) Posted:
Profits us$1.9m ..👍 .. should gap up at opening tomorrow.. let's see.
piscesmonkey ( Date: 24-Feb-2026 17:25) Posted:
|
|
|
And this is only from 1 company.
SmallSmall ( Date: 16-Feb-2026 09:46) Posted:
" For example, assuming 5-10X return on the US$20+ million of invested capital into Phytolon, a sale could fetch US$100-200 million, returning SGD36-76 million to Trendlines (market cap: SGD33 million). "
The above figure was mentioned by Nextinsight was back in 2025.
As Phytolon moves tomwards commercialization, the fruition will get nearer.
DYODD
SmallSmall ( Date: 14-Feb-2026 11:32) Posted:
Trendlines Portfolio Company Achieves FDA Milestone, Paving The Way for Portfolio Company Sale?
Leong Chan Teik
13 February 2026
As consumers increasingly demand products free from synthetic dyes, the race for sustainable natural alternatives has intensified.
On February 9, 2026, The Trendlines Group announced a landmark regulatory victory that positions its portfolio company, Phytolon, at the forefront of this multi-billion dollar market.
The U.S. Food and Drug Administration (FDA) has officially issued an order allowing the use of Phytolon&rsquo s beetroot red food color for human consumption.
This approval, expected to take effect on March 23, 2026, clears the path for the commercialization of Phytolon&rsquo s hue across the entire U.S. food supply.
" The approval enables application in a wide range of food categories, including confectionery, dairy products, beverages, and condiments," said Trendlines.
|
Beyond Agriculture: The Power of Precision Fermentation
Phytolon' s innovation lies in technology using precision fermentation of baker' s yeast while traditional natural colors rely on resource-heavy agriculture&mdash requiring vast fields of beets or other crops.
Phytolon' s biotech approach can produce vibrant purple, red, orange, and yellow hues.
This approach offers several game-changing advantages:
-
Unmatched Efficiency: Through a strategic partnership with Ginkgo Bioworks, Phytolon recently nearly tripled its manufacturing efficiency, ensuring its colors remain cost-competitive with synthetic dyes.
-
Industrial Scalability: Phytolon is preparing to supply the U.S. market through its production lines with subcontractors in Europe.
-
Sustainability: By eliminating the need for land-intensive agriculture, Phytolon provides a " clean-label" solution that significantly reduces water and land use.
A Critical Pivot in Labeling Regulations
Perhaps just as significant as the product approval itself is a simultaneous shift in FDA guidance.
Phytolon co-founders: Dr Halim Jubran (CEO), Dr Tal Zeltzer (Chief Technology Officer).
Fund-raising:
&bull US$4.1 million in Sept 2020 (seed funding)
&bull US$14.5 million Series A in July 2022
&bull Additional funding in Oct 2023
&bull Investment from Rich Products Ventures in Nov 2024 |
The agency has revised its framework regarding " no artificial colors" labeling.
Under these new rules, manufacturers can use this highly desirable label when incorporating natural additives like Phytolon&rsquo s, provided petroleum-based dyes are absent.
Trendlines CEO Haim Brosh noted, &ldquo These developments represent a pivotal inflection point for Phytolon, positioning the company to accelerate market entry, secure initial commercial sales, and pursue strategic partnerships with major food manufacturers in the U.S.
" The Trendlines Group believes that this milestone meaningfully strengthens Phytolon&rsquo s growth trajectory and long-term value creation potential.&rdquo
The Investment Thesis: A High-Potential Exit?
For shareholders of The Trendlines Group (which holds a 25% stake in the company), this milestone represents a pivotal inflection point.
Phytolon has already secured strategic backing from heavyweights like DSM Venturing (the investment arm of a large food ingredient company) and Rich Products Ventures, alongside a global distribution deal with DSM-Firmenich.
With U.S. commercialization now imminent, Phytolon is no longer just a " promising startup" .
As part of Trendlines' broader portfolio, which has seen companies raise over US$100 million in just two years, Phytolon is cementing its position as a prime candidate for a strategic exit. And it has several existing strategic investors which may set off aggressive bidding for the entire Phytolon.
Watch for these developments:
1. Commercial Deals: Announcements of supply agreements or partnerships with major food or beverage brands.
2. Follow-on Funding: News of a new funding round for Phytolon at a significantly higher valuation.
3. Exit Rumors or Announcements: Reports of acquisition talks or an official sale of the company. |
|
|
|
|
|
Ready for the US market comes comes 23 March 2026.
Food Applications & Performance
Phytolon' s pigments are
betalains (similar to those in beets and dragon fruit), which are water-soluble and highly stable under conditions that usually cause natural colors to fade.
Phytolon +4
- Bakery: These colors are heat-stable, making them a rare natural solution for high-pH/high-heat tasks like Red Velvet Cake.
- Plant-Based Meat: They provide a natural color transition from a " raw" frozen look to a " cooked" appearance, integrating well with various plant proteins.
- Dairy & Frozen: They remain vibrant in acidic environments (like yogurt) and are stable against the " heat-cold shocks" common in ice cream production.
- Confectionery & Snacks: Their wide pH stability allows for consistent shades in everything from hard candies to homogenous sauces and dips.
Phytolon +3
Trendlines Returns to Profitability in FY 2025
&bull Group recorded a net gain in the fair value of portfolio companies of US$7.1 million.
&bull Group recorded a net profit attributable to equity holders of US$1.9 million in FY 2025, compared to a loss of US$9.4 million in FY 2024.
&bull IFRS Portfolio Fair Value: US$76.5 million, compared to US$66.1 million as at 31 December 2024
non-IFRS Portfolio Fair Value: US$127.7 million, compared to US$118.9 million as at 31 December 2024
Profits us$1.9m ..👍 .. should gap up at opening tomorrow.. let's see.
piscesmonkey ( Date: 24-Feb-2026 17:25) Posted:
Good result
newbie1118 ( Date: 24-Feb-2026 10:32) Posted:
|
|
|
tom gap up?
piscesmonkey ( Date: 24-Feb-2026 17:25) Posted:
Good result
newbie1118 ( Date: 24-Feb-2026 10:32) Posted:
|
|
|
Boss u got re enter at 62?
piscesmonkey ( Date: 24-Feb-2026 17:25) Posted:
Good result
newbie1118 ( Date: 24-Feb-2026 10:32) Posted:
|
|
|
Good result
newbie1118 ( Date: 24-Feb-2026 10:32) Posted:
|
Slowly waking up?
" For example, assuming 5-10X return on the US$20+ million of invested capital into Phytolon, a sale could fetch US$100-200 million, returning SGD36-76 million to Trendlines (market cap: SGD33 million). "
The above figure was mentioned by Nextinsight was back in 2025.
As Phytolon moves tomwards commercialization, the fruition will get nearer.
DYODDSmallSmall ( Date: 14-Feb-2026 11:32) Posted:
Trendlines Portfolio Company Achieves FDA Milestone, Paving The Way for Portfolio Company Sale?
Leong Chan Teik
13 February 2026
As consumers increasingly demand products free from synthetic dyes, the race for sustainable natural alternatives has intensified.
On February 9, 2026, The Trendlines Group announced a landmark regulatory victory that positions its portfolio company, Phytolon, at the forefront of this multi-billion dollar market.
The U.S. Food and Drug Administration (FDA) has officially issued an order allowing the use of Phytolon&rsquo s beetroot red food color for human consumption.
This approval, expected to take effect on March 23, 2026, clears the path for the commercialization of Phytolon&rsquo s hue across the entire U.S. food supply.
" The approval enables application in a wide range of food categories, including confectionery, dairy products, beverages, and condiments," said Trendlines.
|
Beyond Agriculture: The Power of Precision Fermentation
Phytolon' s innovation lies in technology using precision fermentation of baker' s yeast while traditional natural colors rely on resource-heavy agriculture&mdash requiring vast fields of beets or other crops.
Phytolon' s biotech approach can produce vibrant purple, red, orange, and yellow hues.
This approach offers several game-changing advantages:
-
Unmatched Efficiency: Through a strategic partnership with Ginkgo Bioworks, Phytolon recently nearly tripled its manufacturing efficiency, ensuring its colors remain cost-competitive with synthetic dyes.
-
Industrial Scalability: Phytolon is preparing to supply the U.S. market through its production lines with subcontractors in Europe.
-
Sustainability: By eliminating the need for land-intensive agriculture, Phytolon provides a " clean-label" solution that significantly reduces water and land use.
A Critical Pivot in Labeling Regulations
Perhaps just as significant as the product approval itself is a simultaneous shift in FDA guidance.
Phytolon co-founders: Dr Halim Jubran (CEO), Dr Tal Zeltzer (Chief Technology Officer).
Fund-raising:
&bull US$4.1 million in Sept 2020 (seed funding)
&bull US$14.5 million Series A in July 2022
&bull Additional funding in Oct 2023
&bull Investment from Rich Products Ventures in Nov 2024 |
The agency has revised its framework regarding " no artificial colors" labeling.
Under these new rules, manufacturers can use this highly desirable label when incorporating natural additives like Phytolon&rsquo s, provided petroleum-based dyes are absent.
Trendlines CEO Haim Brosh noted, &ldquo These developments represent a pivotal inflection point for Phytolon, positioning the company to accelerate market entry, secure initial commercial sales, and pursue strategic partnerships with major food manufacturers in the U.S.
" The Trendlines Group believes that this milestone meaningfully strengthens Phytolon&rsquo s growth trajectory and long-term value creation potential.&rdquo
The Investment Thesis: A High-Potential Exit?
For shareholders of The Trendlines Group (which holds a 25% stake in the company), this milestone represents a pivotal inflection point.
Phytolon has already secured strategic backing from heavyweights like DSM Venturing (the investment arm of a large food ingredient company) and Rich Products Ventures, alongside a global distribution deal with DSM-Firmenich.
With U.S. commercialization now imminent, Phytolon is no longer just a " promising startup" .
As part of Trendlines' broader portfolio, which has seen companies raise over US$100 million in just two years, Phytolon is cementing its position as a prime candidate for a strategic exit. And it has several existing strategic investors which may set off aggressive bidding for the entire Phytolon.
Watch for these developments:
1. Commercial Deals: Announcements of supply agreements or partnerships with major food or beverage brands.
2. Follow-on Funding: News of a new funding round for Phytolon at a significantly higher valuation.
3. Exit Rumors or Announcements: Reports of acquisition talks or an official sale of the company. |
|
|
|
Trendlines Portfolio Company Achieves FDA Milestone, Paving The Way for Portfolio Company Sale?
Leong Chan Teik
13 February 2026
As consumers increasingly demand products free from synthetic dyes, the race for sustainable natural alternatives has intensified.
On February 9, 2026, The Trendlines Group announced a landmark regulatory victory that positions its portfolio company, Phytolon, at the forefront of this multi-billion dollar market.
The U.S. Food and Drug Administration (FDA) has officially issued an order allowing the use of Phytolon&rsquo s beetroot red food color for human consumption.
This approval, expected to take effect on March 23, 2026, clears the path for the commercialization of Phytolon&rsquo s hue across the entire U.S. food supply.
" The approval enables application in a wide range of food categories, including confectionery, dairy products, beverages, and condiments," said Trendlines.
|
Beyond Agriculture: The Power of Precision Fermentation
Phytolon' s innovation lies in technology using precision fermentation of baker' s yeast while traditional natural colors rely on resource-heavy agriculture&mdash requiring vast fields of beets or other crops.
Phytolon' s biotech approach can produce vibrant purple, red, orange, and yellow hues.
This approach offers several game-changing advantages:
-
Unmatched Efficiency: Through a strategic partnership with Ginkgo Bioworks, Phytolon recently nearly tripled its manufacturing efficiency, ensuring its colors remain cost-competitive with synthetic dyes.
-
Industrial Scalability: Phytolon is preparing to supply the U.S. market through its production lines with subcontractors in Europe.
-
Sustainability: By eliminating the need for land-intensive agriculture, Phytolon provides a " clean-label" solution that significantly reduces water and land use.
A Critical Pivot in Labeling Regulations
Perhaps just as significant as the product approval itself is a simultaneous shift in FDA guidance.
Phytolon co-founders: Dr Halim Jubran (CEO), Dr Tal Zeltzer (Chief Technology Officer).
Fund-raising:
&bull US$4.1 million in Sept 2020 (seed funding)
&bull US$14.5 million Series A in July 2022
&bull Additional funding in Oct 2023
&bull Investment from Rich Products Ventures in Nov 2024 |
The agency has revised its framework regarding " no artificial colors" labeling.
Under these new rules, manufacturers can use this highly desirable label when incorporating natural additives like Phytolon&rsquo s, provided petroleum-based dyes are absent.
Trendlines CEO Haim Brosh noted, &ldquo These developments represent a pivotal inflection point for Phytolon, positioning the company to accelerate market entry, secure initial commercial sales, and pursue strategic partnerships with major food manufacturers in the U.S.
" The Trendlines Group believes that this milestone meaningfully strengthens Phytolon&rsquo s growth trajectory and long-term value creation potential.&rdquo
The Investment Thesis: A High-Potential Exit?
For shareholders of The Trendlines Group (which holds a 25% stake in the company), this milestone represents a pivotal inflection point.
Phytolon has already secured strategic backing from heavyweights like DSM Venturing (the investment arm of a large food ingredient company) and Rich Products Ventures, alongside a global distribution deal with DSM-Firmenich.
With U.S. commercialization now imminent, Phytolon is no longer just a " promising startup" .
As part of Trendlines' broader portfolio, which has seen companies raise over US$100 million in just two years, Phytolon is cementing its position as a prime candidate for a strategic exit. And it has several existing strategic investors which may set off aggressive bidding for the entire Phytolon.
Watch for these developments:
1. Commercial Deals: Announcements of supply agreements or partnerships with major food or beverage brands.
2. Follow-on Funding: News of a new funding round for Phytolon at a significantly higher valuation.
3. Exit Rumors or Announcements: Reports of acquisition talks or an official sale of the company. |
|
Watch Trendlines for fireworks. Good to accumulate.
Trendlines Portfolio Company Achieves FDA Milestone, Paving The Way for Portfolio Company Sale? https://www.nextinsight.net/story-archive-mainmenu-60/949-2026/16579-trendlines-portfolio-company-achieves-fda-milestone-paving-the-way-for-portfolio-company-sale
Boss u scoop how many lots at 62? Congrates.
piscesmonkey ( Date: 10-Feb-2026 13:59) Posted:
I bought 62 sold at 69
Stocky901 ( Date: 10-Feb-2026 13:53) Posted:
| Better cut loss and buy back on dips.. don't expect any profit in coming results..🧐 🧐 |
|
|
|
